Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0.704. It has been cited 20 times, with 19 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0.247
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 19 citers.
NIDDK NIH HHS
Grant: R01 DK122566
NIDDK NIH HHS
Grant: R01 DK099317
NIDDK NIH HHS
Grant: R01 DK081166
NIDDK NIH HHS
Grant: R01 DK032083
NIDDK NIH HHS
Grant: R01 DK108868
NIAID NIH HHS
Grant: R21 AI133059
NIDDK NIH HHS
Grant: T32 DK120520
NIDDK NIH HHS
Grant: P30 DK116073
NIAID NIH HHS
Grant: R01 AI146202
National Institutes of Health
Grant: 5R01DK122566-04
T cell repertoire for hybrid insulin peptides
National Institutes of Health
Grant: 5P30DK116073-03
UC Denver Diabetes Research Center
National Institutes of Health
Grant: 5R21AI133059-02
T cells reactive to Hybrid Insulin Peptides (HIPs) as biomarkers in autoimmune diabetes
National Institutes of Health
Grant: 5R01DK081166-12
Hybrid Peptides as Autoantigens for Diabetogenic CD4 T Cells
National Institutes of Health
Grant: 5T32DK120520-02
Interdisciplinary Bioengineering Research Training in Diabetes
National Institutes of Health
FWCI
3.21
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals